This is a summary of a manuscript Dr. Tettelbach, Martha Kelso, and I put together.
In the evolving field of wound care, Cellular, Acellular, and Matrix-like Products (CAMPs) have significantly improved healing rates and cost-effectiveness, supported by numerous randomized controlled trials (RCTs) and real-world data (RWD). Despite these advancements, recent proposed draft Local Coverage Determinations (LCDs) by Medicare Administrative Contractors (MACs) may not fully align with the current evidence base, potentially impacting clinical outcomes and patient care.
Understanding the Impact of CAMPs
CAMPs have demonstrated their efficacy in creating protective barriers over hard-to-heal wounds, reducing inflammation, and promoting tissue growth. The therapeutic benefits of CAMPs include pain alleviation, decreased fluid loss, lower infection and amputation rates, and improved patient quality of life. Over the past two decades, wound care specialists have increasingly integrated CAMPs into their treatment protocols, driven by strong evidence from multiple prospective multicenter RCTs and supportive observational studies.
Evidence-Based Medicine vs. Policy
The draft LCDs propose limiting the application of CAMPs to four within a 12-week treatment episode. However, this restriction does not consider the variability in wound types and patient needs. For example, venous leg ulcers (VLUs) and diabetic foot ulcers (DFUs) often require more than four applications, especially in complex cases with significant wound depth or infection. A detailed analysis of Medicare claims data from 2015 to 2019 revealed that adhering to a strict four-application limit does not reflect real-world usage and could hinder optimal patient care.
The Need for Flexibility and Education
The proposed LCDs also fail to address the importance of timely CAMP application and the need for ongoing education of wound care providers. The data shows that CAMPs are most effective when applied within 30–45 days of the first wound care visit and used regularly until the wound heals or treatment fails. Unfortunately, less than 10% of providers apply CAMPs within this optimal timeframe. To bridge this gap, enhanced educational initiatives and standardization of wound care training are essential.
Addressing Billing and Coding Challenges
The LCDs introduce the use of the KX modifier for exceptional cases requiring more than four CAMP applications. However, this approach could create significant administrative burdens and delays in patient care. Moreover, the current billing and coding guidelines do not adequately cover deeper wounds involving muscle or bone, which are at higher risk for amputation if not treated effectively.
Recommendations for Policy Improvement
To better align the draft LCDs with evidence-based practices, several recommendations are proposed:
- Increase the Allowable Number of CAMP Applications: Based on retrospective Medicare data and RCTs, expanding the limit to eight applications within a 12-week period would better reflect clinical needs and improve patient outcomes.
- Clarify KX Modifier Usage: Define specific clinical criteria for wound progression to justify the use of additional CAMP applications, ensuring transparency and reducing administrative burdens.
- Enhance Wound Care Education: Promote standardized training programs for wound care providers to ensure the optimal use of CAMPs and improve overall patient care.
- Include ICD-10 Codes for Complex Wounds: Update billing and coding guidelines to cover wounds involving deep structures, facilitating comprehensive treatment options.
Conclusion
The proposed draft LCDs for CAMPs represent a step towards standardizing wound care based on medical evidence. However, to truly enhance clinical outcomes and patient quality of life, policymakers must re-evaluate data interpretations and provide clearer guidelines for the use of CAMPs. By aligning policy with evidence-based practices, the healthcare community can better serve patients with hard-to-heal wounds and drive improvements in wound care management.
Leave a Reply